Fetal diagnosis and therapy · 2025
Referral for Dilated Fetal Rectum: Rarely a Pathologic Entity.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Scire Emily M, Estroff Judy A, Barnewolt Carol E, Didier Ryne A, Zurakowski David, Buchmiller Terry L
Аннотация
INTRODUCTION: Dilated colon or rectum on fetal imaging raises concern for underlying anorectal malformation (ARM) or Hirschsprung's disease (HD).
METHODS: We evaluated pregnant women referred to a dedicated fetal center between 2006 and 2024 for suspected fetal rectal/colonic dilation. Findings by ultrasound and magnetic resonance imaging were compared to neonatal outcomes. Those with a statistically significant association with postnatal distal bowel abnormality were identified by univariate analysis and used to formulate a risk score.
RESULTS: A total of 18/47 (38.2%) patients had normal imaging. A total of 29/47 (61.7%) demonstrated persistent "prominence" (15/29) or "dilation" (14/29) of the fetal colon/rectum. Seven male fetuses with large bowel dilation/prominence were diagnosed postnatally with an imperforate anus. None had HD. Compared to the no-ARM group, ARM patients were more likely to have earlier initial referral imaging; imaging noting persistent bowel dilation/prominence; imaging with an abnormal amniotic fluid level, meconium signal, bowel echogenicity, or anal sphincter; enterolithiasis; or concern for VACTERL (all p ≤ 0.035). These 8 variables were used to create a risk score to diagnose ARM with 100% sensitivity and specificity in our cohort.
CONCLUSION: Fetal imaging showing a dilated colon/rectum is rarely pathologic. When targeted imaging does not reveal any features predictive of pathology, reassurance may be provided to families and providers.
METHODS: We evaluated pregnant women referred to a dedicated fetal center between 2006 and 2024 for suspected fetal rectal/colonic dilation. Findings by ultrasound and magnetic resonance imaging were compared to neonatal outcomes. Those with a statistically significant association with postnatal distal bowel abnormality were identified by univariate analysis and used to formulate a risk score.
RESULTS: A total of 18/47 (38.2%) patients had normal imaging. A total of 29/47 (61.7%) demonstrated persistent "prominence" (15/29) or "dilation" (14/29) of the fetal colon/rectum. Seven male fetuses with large bowel dilation/prominence were diagnosed postnatally with an imperforate anus. None had HD. Compared to the no-ARM group, ARM patients were more likely to have earlier initial referral imaging; imaging noting persistent bowel dilation/prominence; imaging with an abnormal amniotic fluid level, meconium signal, bowel echogenicity, or anal sphincter; enterolithiasis; or concern for VACTERL (all p ≤ 0.035). These 8 variables were used to create a risk score to diagnose ARM with 100% sensitivity and specificity in our cohort.
CONCLUSION: Fetal imaging showing a dilated colon/rectum is rarely pathologic. When targeted imaging does not reveal any features predictive of pathology, reassurance may be provided to families and providers.